• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Asperosaponin VI

Asperosaponin VI

Product ID A7461
Cas No. 39524-08-8
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $67.40 In stock
25 mg $134.80 In stock
100 mg $449.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Asperosaponin VI is a triterpene saponin found in the Dipsacus asper plant. Asperosaponin VI displays cardioprotective and antioxidative activities. In animal models, this compound protects the heart from ischemic injury by decreasing levels of lactate dehydrogenase, creatine kinase, glutamic oxalacetic transaminase, and cardiac troponin T, and increasing levels of radical scavenging enzymes such as glutathione peroxidase and superoxide dismutase. Asperosaponin VI also inhibits apoptosis in hypoxic cardiac myocytes, increasing the Bcl-2/Bax ratio and decreasing caspase-3 expression. In an animal model of cardiac fibrosis, this compound improves left ventricle systolic pressure and left ventricle end-diastolic pressure by decreasing expression of pro-inflammatory cytokines IL-6 and TNF-α.

Product Info

Cas No.

39524-08-8

Purity

≥98%

Formula

C47H76O18

Formula Wt.

929.10

IUPAC Name

[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (6aS,9R)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

Synonym

Akebia Saponin D

Appearance

White Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A7461 MSDS PDF

Info Sheet

A7461 Info Sheet PDF

References

Li C, Gao Y, Tian J, et al. Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction. Food Chem Toxicol. 2012 May;50(5):1432-8. PMID: 22343037.

Li C, Tian J, Li G, et al. Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways. Eur J Pharmacol. 2010 Dec 15;649(1-3):100-7. PMID: 20863824.

Li C, Liu Z, Tian J, et al. Protective roles of Asperosaponin VI, a triterpene saponin isolated from Dipsacus asper Wall on acute myocardial infarction in rats. Eur J Pharmacol. 2010 Feb 10;627(1-3):235-41. PMID: 19909736.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T6930

    Triclosan Methyl Ether

    Diarylether; bacterial ENR binder, fatty acid synt...
    ≥99%
  • R2815

    Recombinant HIV-1 “0” group consensus

    Recombinant HIV-1 antigen fragment.
    ≥95%
  • T286161

    Theaflavin

    Polyphenolic compound present in black tea.
    ≥98%
  • N3346

    Nilotinib

    Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A inhi...
    ≥98%
  • I4962

    Isoimperatorin

    Furocoumarin; COX-2 inhibitor.
    ≥98%
  • K0054

    Kanamycin B

    Aminoglycoside; protein translation inhibitor, mam...
    ≥98%
  • N1984

    Neuropeptide FF

    Endogenous RF-amide peptide, involved in nocicepti...
    ≥95%
  • D0263

    Dapoxetine Hydrochloride

    SERT inhibitor, potential voltage-gated K+ channel...
    ≥99%
  • T1654

    Tenoxicam

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • G1849

    Gemifloxacin Mesylate

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • P4782

    PluriSIn 1

    Stearoyl-coA desaturase 1 inhibitor.
    ≥98%
  • T1672

    Terbinafine Hydrochloride

    Allylamine; squalene oxidase and KSR1 inhibitor.
    ≥98%
  • R0251

    Ranatensin R

    Peptide found in amphibians, neuromedin B analog.
    ≥98%
  • P2818

    Phentolamine Methanesulfonate

    ATP-sensitive K+ channel activator, α-adrenergic ...
    ≥98%
  • T7032

    Triamcinolone

    Synthetic steroid; glucocorticoid agonist.
    ≥98%
  • C6132

    CPI-203

    Triazolothienodiazepine, JQ-1 derivative; BRD inhi...
    ≥99%
  • T0003

    T2 Tetraol

    Trichothecene mycotoxin produced by Fusarium.
    ≥97%, TLC
  • P3076

    PHT-427

    PDK1 and Akt inhibitor.
    ≥98%
  • C0254

    Candesartan Celexetil Ester

    AT1 inhibitor.
    ≥98%
  • A6827

    Argipressin Acetate

    Endogenous peptide, involved in vascular contracti...
    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only